SCHINDLER, Thomas. Will the Food and Drug Administration’s New Standard of Requiring Only One Trial for a New Drug Application/Biologic License Application Have Repercussions for Medical Communicators?. AMWA Journal, Rockville, MD, v. 41, n. 2, 2026. DOI: 10.55752/amwa.2026.569. Disponível em: https://www.amwajournal.org/index.php/amwa/article/view/569. Acesso em: 18 jun. 2026.